Introducing “Bench to Bedside With SIDP,” a new column from the Society for Infectious Diseases Pharmacists covering everything from antimicrobial stewardship and pharmacokinetics/pharmacodynamics to mentorship, preceptorship, and more.
Clinical Considerations in Conducting Antifungal Susceptibility Testing
July 6th 2022Access to antifungal susceptibility testing (AFST) remains limited in the United States. Therefore, providers must recognize clinical situations where AFST will provide its greatest value. In the latest article from SIDP, infectious disease pharmacists offers some insights on this subject.
Read More
Bacteriophage-Antibiotic Combinations: A Promising Alternative for Refractory Infections?
Despite the initial abandonment of bacteriophages in most areas of the world, the era of antibiotic resistance has led to a resurgence of phage therapy in clinical practice.
Read More
When using ceftolozane/ tazobactam to treat patients with P aeruginosa respiratory tract infections, the use of extended or continuous antibiotic infusion and/or combination therapy with other active antibiotic agents should be considered, particularly if targeting higher MIC values.
Read More
Preliminary Negative Cultures for the De-Escalation of MRSA Therapy
December 16th 2019This article evaluates the point in microbiological workup at which results of respiratory secretion and blood cultures could be interpreted as excluding MRSA and, thus, no longer warrant the empirical vancomycin therapy.
Read More